Anti-inflammation Treatment for Idiopathic Inflammatory Myopathies
NCT07668505
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Myositis
Interventions
DRUG:
maraviroc (Selzentry, Celsentri)
Sponsor
Chinese University of Hong Kong